Updated
Original VAYEMA symptom and impact self-check – not a validated scale
Prescription opioid concerns
Answer the symptom statements below to see which experiences and areas of daily life you report as most affected. These are original VAYEMA questions, not a validated diagnostic scale. No clinical severity or probability score is calculated.
Answers are processed only in this page by this assessment. They are not submitted, monitored or automatically saved. No name, email or account is required. Use a private device and clear your answers when finished.
For adults aged 18 and over. This self-check cannot diagnose or rule out a condition. Concerns about a child require an age-appropriate professional assessment.
Thinking about the past four weeks, how well does each statement describe your experience?
Additional context – not included in any questionnaire score
These are original VAYEMA questions, not a diagnostic instrument or a validated severity scale. They summarize the experiences you select and do not predict a diagnosis or future harm. Background condition information; this source does not endorse this self-check.
Begin with the pain condition and the question you want answered
Explain why the opioid was started, what the original diagnosis was and whether circumstances have changed. You may want to reduce side effects, understand dependence, review limited benefit or discuss a proposed taper. Those are different questions. A careful assessment starts with the person and the condition rather than assumes that every opioid prescription must lead to the same recommendation.
The CDC prescription-opioid overview recognizes legitimate treatment uses as well as risks. Acute pain, chronic non-cancer pain, cancer-related care and palliative treatment may need different expertise. Tell the professional who currently manages your condition. A guideline from one setting should not replace an individual assessment in another. Your pain remains relevant even when the main reason for the appointment is concern about medication.
Bring an accurate current medication account
The clinician may need the name, formulation, prescribed instructions, actual use and approximate duration. Include prescriptions from other services and any non-prescribed products. A pharmacy record or current list can help, but you do not need a perfectly reconstructed history before requesting review. State what you know and where dates or details are uncertain.
Do not calculate dose equivalents or substitute a product while preparing. Different formulations can have different implications, and a medicine’s appearance is not a reliable way to identify an unregulated pill. The SAMHSA resource explains concerns about counterfeit prescription products. If the source or contents are uncertain, tell the clinician directly. The aim is safe care, not a judgment about whether your account sounds sufficiently orderly.
Describe function, comfort and adverse effects together
A review should ask what the medicine helps you do as well as how much pain you report. Sleep, mobility, self-care, concentration and participation can be useful discussion points. There may be benefit in one area and unwanted effects in another. A single number cannot capture the whole balance, and a person should not feel required to exaggerate pain to keep it taken seriously.
Mention constipation, nausea, drowsiness, unsteadiness or other concerns without assuming the cause. The clinician can consider the opioid, other medicines and underlying health. CDC guidance on continuing therapy centers review on individual benefits and risks. A recommendation should connect those observations to a plan rather than rely only on dose, duration or the fact that a prescription has been repeated for years.
Understand why dependence is assessed separately from addiction
Physical dependence can develop during appropriate opioid treatment and can cause symptoms when the medicine is reduced or stopped. A substance-use disorder requires a broader assessment of the pattern and consequences. The CDC diagnostic resource explains that tolerance and withdrawal are not counted as criteria when opioids are used solely under appropriate medical supervision.
The clinician may still ask about loss of control, use outside the plan or continued use despite harm. These questions should not be accusatory. Needing relief from pain, fearing withdrawal and experiencing compulsive use can be difficult to distinguish from a brief description. A professional should explore the context rather than conclude from one phrase. Our understanding guide explains why the distinction changes the support that may be appropriate.
Previous reductions and supply interruptions matter
Tell the clinician about missed doses, running out, sudden changes or earlier tapers and what happened afterward. Include physical symptoms, changes in pain, sleep and mood, and any urgent medical care. The timing may help distinguish withdrawal from the original condition or another problem. It does not establish the explanation on its own, so uncertainty should be acknowledged rather than filled with guesses.
Do not deliberately provoke symptoms before assessment. NICE NG215 supports planned withdrawal and continued treatment of the underlying condition. A difficult earlier attempt can inform a safer or better-supported plan without proving that reduction is impossible. If supply is currently running out or symptoms are serious, contact the responsible prescriber or appropriate urgent service instead of waiting for a routine private appointment.
Other medicines and overdose history can change priorities
Alcohol, benzodiazepines, sleeping medicines and other sedating products can affect opioid safety. Include all relevant prescriptions, substances and health conditions, particularly breathing concerns or episodes of marked sedation. Previous overdose, naloxone administration or emergency treatment should be discussed directly. A medicine being prescribed does not rule out a serious interaction or a need for closer review.
Do not independently stop several medicines to simplify the assessment. The professional may need to coordinate changes and decide which concern is most urgent. The CDC patient guidance explains both interaction risks and the need to avoid unsupported abrupt discontinuation. An assessment should make responsibilities clear rather than leave you to combine advice from separate services without a shared plan.
Tests and questionnaires have limited roles
A clinician may use structured questions, examine physical health or recommend investigations for a particular concern. Drug testing can provide selected information about exposure but does not independently diagnose addiction, explain pain or determine that a taper is safe. The history and current condition remain important. A negative or unexpected result needs interpretation rather than an automatic judgment about the person.
The worksheet here does not reproduce a validated opioid-risk instrument or calculate a withdrawal score. It has no pass mark, dose recommendation or prediction of misuse. More testing is not always more informative; ask what a proposed measure would add and how it would affect care. You can request a professional conversation without a completed form, a certain symptom total or proof that you have already tried to stop.
Include mood, sleep and the realities of daily life
Pain and medication concerns can affect confidence, relationships and emotional well-being. Anxiety or low mood may also need assessment in their own right. Discuss these alongside physical symptoms rather than assume they explain all the pain. A helpful review takes both seriously and identifies any urgent mental health concern directly, not through an unmonitored worksheet.
Explain practical circumstances such as work, caring responsibilities or difficulty attending appointments. These do not override safety, but they affect how a plan can be followed. With agreement, care coordination can support records and appointments, and family support can address relatives’ own needs. Their involvement should not transfer prescription decisions to family members or remove your right to private clinical discussion.
Ask what the assessment changes about your care
The recommendation may involve continuing with review, supervised reduction, another pain approach, assessment for opioid-use disorder or specialist referral. The clinician should explain why, what remains uncertain and who is responsible. A diagnosis alone is not a complete plan. Ask what will happen first, what follow-up is arranged and how questions or worsening symptoms can be addressed.
The treatment guide describes these paths. If opioid-use disorder is identified, the specific treatment page explains why medication and ongoing support may be important. A short detoxification or a universal taper should not be assumed sufficient for every presentation. Equally, physiological dependence alone does not automatically justify a large addiction program when a focused review would be appropriate.
Keep preparation private and urgent action direct
Nothing entered in the notes is sent to VAYEMA, monitored or added to a patient record. A file you deliberately download is under your control and should be stored privately. Leave fields blank if they are not useful and share detailed information only through an agreed clinical channel. You can bring a spoken account instead; preparation should reduce the burden of an appointment, not create another obstacle.
For planned input, the VAYEMA assessment pathway can clarify suitable expertise and scope. Suspected overdose requires emergency services. Where an opioid overdose is possible, use available naloxone according to its instructions while help is called and follow dispatcher guidance; the CDC resource explains its purpose. Do not rely on a worksheet or routine inquiry to report an emergency or obtain immediate prescription advice.
Frequently asked questions about prescription opioid assessment
Will the assessment assume that needing pain relief is addiction?
It should not. Pain, physical dependence and opioid-use disorder need separate assessment. A person can need medical pain care and also have medication concerns. The clinician should review the actual pattern and consequences rather than diagnose from dose, duration or withdrawal alone. Honest discussion should lead to appropriate support, not blame.
What records should I bring?
A current medication list, information about the pain condition and any earlier treatment or difficult reductions can help. Exact records are useful when available but not a prerequisite for requesting assessment. Mark uncertain details as uncertain. Urgent symptoms or a supply problem should be addressed directly rather than delayed while documents are collected.
Can the worksheet calculate a safe lower dose?
No. It contains no dose equivalents, withdrawal score or taper recommendation. Formulation, history, current symptoms and other medicines require professional judgment. Do not change medication based on an online result. Ask the responsible prescriber for an individual plan and clear arrangements for review and questions.
Does an abnormal drug test establish addiction?
A test can provide information within its limits, but it does not independently assess impaired control, function, pain or the whole clinical situation. Results need interpretation alongside the history and examination. Ask what a test is intended to clarify rather than assume that a laboratory result alone settles the diagnosis or treatment plan.
What if I disagree with a proposed taper?
Explain your concerns, what benefit the medicine provides and what happened during earlier changes. The clinician should discuss benefits, risks, alternatives and continuing pain care. The goal is a reasoned plan, not abrupt withdrawal of support. You can ask for clarification or another professional opinion where appropriate.
Will entering a serious concern alert the clinic?
No. Worksheet answers are not transmitted or monitored. For abnormal breathing, inability to wake normally, collapse or suspected overdose, contact local emergency services. Prescription supply and current withdrawal concerns also need direct professional advice. The notes are optional preparation, not an emergency or prescribing channel.
Resources and references
[1] CDC: prescription opioid basics
[2] CDC: reviewing continuing opioid therapy
[3] CDC: opioid-use-disorder diagnosis
[4] NICE NG215: dependence and safe medication changes
[5] CDC: patient questions about prescription opioids
[6] SAMHSA: prescription medicine and counterfeit-pill concerns